Independent Advisor Alliance
Source: SEC Form 13F · as of Mar 2026Independent Advisor Alliance holds 20 biotech & pharma companies tracked by BioSniper, totaling $9.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$9.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 33,486 | $4.7M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 15,618 | $862K |
| ARQTArcutis Biotherapeutics, Inc. | 31,597 | $744K |
| REGNREGENERON PHARMACEUTICALS, INC. | 725 | $560K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,602 | $530K |
| ABSIAbsci Corporation | 153,855 | $462K |
| INCYIncyte Corp. | 4,794 | $451K |
| GPCRStructure Therapeutics Inc. | 7,444 | $359K |
| SNYSanofi | 7,110 | $343K |
| INSMINSMED Inc | 1,434 | $234K |
| VKTXViking Therapeutics, Inc. | 6,185 | $201K |
| CMPXCompass Therapeutics, Inc. | 17,894 | $95K |
| AVXLANAVEX LIFE SCIENCES CORP. | 30,576 | $94K |
| KLRSKalaris Therapeutics, Inc. | 14,230 | $82K |
| NRSNNeuroSense Therapeutics Ltd. | 50,000 | $38K |
| AUTLAutolus Therapeutics plc | 22,340 | $31K |
| EVOEvotec SE | 11,828 | $30K |
| ESPREsperion Therapeutics, Inc. | 10,053 | $28K |
| GNTAGenenta Science S.p.A. | 37,036 | $25K |
| HUMAHumacyte Inc. | 26,500 | $16K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.